Developer docs
API playgroundTry for free, no card

Search company profiles

Diagnose.me

Full company profile

uuid000jnos

Namestring
Diagnose.me
Legal namestring
Diagnose.me BV
Websiteurl
diagnose.me
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Diagnose.me is a digital health platform founded in 2012 and headquartered in Rumpt, the Netherlands, that connects patients with internationally vetted medical specialists for expert second opinions. The platform operates three core services: an Expert Medical Opinion offering where patients select a specialist, upload medical data, and receive a detailed written report with two free follow-up questions; Personalised Oncology, which provides targeted cancer treatment recommendations based on molecular and genetic tumour profiling delivered through partners Oncompass and Multiplex DX; and Pathology Review via the biopsy.me sub-brand, an independent biopsy analysis service connecting patients to a network of board-certified pathologists. Specialist credentials are gated by a Medical Advisory Board of ten world-renowned radiology and surgery experts who enforce strict academic, clinical, and communication criteria before admission to the network. The platform supports 25+ languages and serves patients from 80+ countries.

The underlying technology combines a multilingual marketplace and case-management workflow with AI-assisted radiology tooling used by specialists to interpret medical images, plus integrations with third-party molecular diagnostics providers for oncology. Diagnose.me holds no patents or proprietary AI models disclosed in the source data, and its technology moat centres on the curated specialist network, Medical Advisory Board vetting, and accumulated case corpus rather than owned model IP.

Diagnose.me monetises through two primary channels. The dominant go-to-market is B2B partnership licensing with 25+ insurance companies and banks (KBC, Raiffeisen, UniCredit, NN, Hannover Re, Vienna Insurance Group brands, etc.) across 15+ Central and Eastern European countries, where services are embedded as employee benefits or policy add-ons reaching 3.5M+ members. A secondary direct-to-consumer channel allows individual patients to self-serve and pay per consultation, with specialists setting their own fees and turnaround times, while oncology tests are priced at €2,500-€3,900 per case. The company is privately held, has raised approximately $638K of disclosed venture funding across 2012-2015, and operates with 11-50 employees.

Short descriptiontext

Diagnose.me is a Netherlands-based digital health platform founded in 2012 that connects patients from 80+ countries with internationally vetted medical specialists for expert second opinions, personalised oncology, and pathology review, distributed primarily through B2B partnerships with 25+ insurance companies and banks.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAmsterdam, Netherlands
HQ citystring
Amsterdam
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical second opinions, telemedicine consultations, personalised oncology services, digital health platform, pathology review services
Industry3 codes
PRIMARYHLALALAC
Second Opinion & Expert Matching Platforms
Healthcare & Life Sciences/Telehealth Platforms/Telehealth Marketplace & Referral Platforms
SECONDARYHLALADAI
Second Opinion & Expert Medical Review Platforms
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms
SECONDARYHLAAALAE
Oncology Diagnostics (tumor profiling, MRD, liquid biopsy)
NAICS code1 code
  • Ambulatory Health Care Services621
SIC code1 code
  • Services-Health Services8000
Product category
Telemedicine Medical Second Opinion Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Expert Medical Opinion Consultation Fees
TypeOne Time License
Description

Specialists set their own consultation fees and delivery times. Patients pay for expert medical opinions from international specialists across various medical specializations.

diagnose.me
2Personalised Oncology Testing
TypeOne Time License
Description

Diagnostic testing services for cancer treatment personalization. Providers include Oncompass (€3900) and Multiplex DX (€2500), providing comprehensive molecular profiling and treatment recommendations based on tumor genetic features.

diagnose.me
3Pathology Review Service
TypeOne Time License
Description

Biopsy evaluation service provided through biopsy.me network of international pathologists, analyzing tumor specimens to determine cancer subtypes.

diagnose.me
4B2B Partnership Licensing
TypeSubscription Recurring
Description

Insurance companies and banks integrate Diagnose.me services as employee benefits or policy add-ons. Partnership models include free benefits for customers, paid add-ons, or themed packages linked to specific policies.

diagnose.me
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details3 tiers
1Oncompass comprehensive molecular profiling
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Oncompass from €3900 - Comprehensive molecular profiling, personalised therapy planning and clinical interpretation with report in English. EU services include tumour board access and direct decision support.

diagnose.me
2Multiplex DX breast cancer testing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Multiplex DX from €2500 - Diagnostic test for breast cancer, available in EU countries with report in English or Slovak.

diagnose.me
3Expert Medical Opinion - Specialist Consultation
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Every specialist determines their own fee and delivery time. Patients receive detailed reports in preferred language with two free follow-up questions.

diagnose.me
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1biopsy.me
Description

Telepathology service provided by Diagnose.me that connects patients to an international network of board-certified pathologists for biopsy reviews.

diagnose.me
Core offering1 text field

Diagnose.me operates a digital health platform that connects patients with a curated network of international medical specialists for expert second opinions, personalised oncology treatment guidance, and pathology review. Patients select specialists, upload medical data, and receive detailed reports in their preferred language, with services delivered via a web-based platform supporting 25+ languages. The company also offers B2B partnership integrations where insurance companies and banks bundle Diagnose.me services as employee benefits or policy add-ons.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 70% of sales agents report higher conversion rates when offering Diagnose.me services
+4 more records
Product overview1 text field

Diagnose.me is a digital health platform that provides a curated network of international medical specialists offering expert second opinions. The platform operates three interconnected services: Expert Medical Opinion as the core product for general diagnostic consultations, Personalised Oncology for targeted cancer treatment recommendations based on molecular profiling (providers include Oncompass and Multiplex DX), and Pathology Review for independent biopsy analysis through biopsy.me. All services are delivered via a web-based platform with support for 25+ languages, connecting patients from 80+ countries with specialists from top international hospitals and institutions.

Product and service3 records
1Expert Medical Opinion
2Personalised Oncology
3Pathology Review
Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership31 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major insurance partner integrating Diagnose.me services into their product offerings. Bulstrad Life, part of Vienna Insurance Group, offers second medical opinion as part of their life insurance products.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Ukrainian life insurance company providing Diagnose.me services to policyholders. Partnership has delivered services to thousands of clients since inception.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Dutch insurance company offering Diagnose.me as health benefits package to Slovak clients. Over 10,000 clients benefited in first three years.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Insurance company partner providing second medical opinion services to policyholders.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Insurance partner offering Diagnose.me services to customers.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Croatian insurance company partner.

7Donaris
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Moldovan insurance company partner.

diagnose.me
8Global Assistance Poland
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Assistance services provider in Poland.

diagnose.me
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Insurance partner.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major reinsurance company partner providing support for insurance products.

11IRAO
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Insurance partner.

diagnose.me
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Belgian banking and insurance group with presence across CEE.

13Komunalna poistovna
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Slovak insurance company partner.

diagnose.me
14Kooperativa
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Slovak insurance company partner (Vienna Insurance Group).

diagnose.me
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Insurance company partner.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

North Macedonian insurance partner.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Polish banking institution partner offering Diagnose.me services.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Azerbaijani life insurance partner.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Bulgarian bank partner.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

International banking group with presence across CEE.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Slovak banking institution partner offering Diagnose.me services through benefits programs.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

International banking group partner in Slovakia and Czech Republic.

23Union Hungary
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Hungarian insurance company partner.

diagnose.me
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Austrian insurance group with CEE presence.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Life insurance brand of Vienna Insurance Group.

26biopsy.me
Strategic tierCoreTypeTechnology or Integration
Description

Telepathology service provider connecting patients to an international network of board-certified pathologists for comprehensive and precise diagnostic evaluations.

diagnose.me
Strategic tierCoreTypeTechnology or Integration
Description

Provider of comprehensive molecular profiling and personalised therapy planning for cancer treatment. Services include clinical interpretation and tumour board access for EU patients.

Strategic tierCoreTypeTechnology or Integration
Description

Provider of diagnostic tests for breast cancer, available in EU countries with reports in English or Slovak.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Top international hospital and institution part of Diagnose.me's global medical network providing specialist expertise.

30Rambam Health Care Campus
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading medical institution in Diagnose.me's global specialist network.

diagnose.me
31Dr. Berezin Medical Center
Strategic tierCoreTypeStrategic or Co-development Partner
Description

International medical institution providing specialists to Diagnose.me network.

diagnose.me
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Best Doctors pioneered the expert medical second opinion model and is now part of Teladoc Health; it is the closest direct competitor, offering cross-border expert reviews to insurance and employer clients globally.

TypeBroad incumbent
Description

AXA's embedded second opinion benefit available to policyholders via partnerships; a broader incumbent offering overlapping second opinion capabilities as part of a much larger insurance and health portfolio.

TypeBroad incumbent
Description

Largest global telehealth platform offering virtual care, expert medical services and second opinions; broader incumbent whose portfolio includes direct competitors (Best Doctors) to Diagnose.me's expert review offering.

TypeDirect peer
Description

Global second medical opinion provider primarily serving insurance and financial services clients; overlaps directly with Diagnose.me's insurance-embedded B2B model across multiple geographies.

TypeDirect peer
Description

Telemedicine and expert medical opinion provider serving insurers, employers and governments worldwide; competes with Diagnose.me in cross-border expert opinion delivery to payer clients.

TypeBroad incumbent
Description

Online medical second opinion service from Cleveland Clinic offering expert reviews for a fee; an academic-medical-center incumbent whose offerings compete for the same patient-paid second opinion demand.

TypeDirect peer
Description

Provides international medical second opinions and e-health services to insurance, assistance and corporate clients, comparable in cross-border expert review delivery and payer partnerships.

TypeDirect peer
Description

US-based second opinion service acquired by Accolade, connecting employees of large US employers with specialist experts for case reviews; directly comparable in product, B2B distribution model and clinical opinion flow.

TypeDirect peer
Description

Global medical management and second opinion company serving insurance and corporate clients across multiple continents; comparable in B2B payer-embedded second opinion and care navigation.

TypeBroad incumbent
Description

Global healthcare marketplace connecting patients with specialists and enabling online consultations; broader incumbent in patient-specialist matching with overlapping online second opinion use cases.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Diagnose.me

Telemedicine Medical Second Opinion Servicesdiagnose.me

Diagnose.me is a Netherlands-based digital health platform founded in 2012 that connects patients from 80+ countries with internationally vetted medical specialists for expert second opinions, personalised oncology, and pathology review, distributed primarily through B2B partnerships with 25+ insurance companies and banks.

What Diagnose.me does

Diagnose.me is a digital health platform founded in 2012 and headquartered in Rumpt, the Netherlands, that connects patients with internationally vetted medical specialists for expert second opinions. The platform operates three core services: an Expert Medical Opinion offering where patients select a specialist, upload medical data, and receive a detailed written report with two free follow-up questions; Personalised Oncology, which provides targeted cancer treatment recommendations based on molecular and genetic tumour profiling delivered through partners Oncompass and Multiplex DX; and Pathology Review via the biopsy.me sub-brand, an independent biopsy analysis service connecting patients to a network of board-certified pathologists. Specialist credentials are gated by a Medical Advisory Board of ten world-renowned radiology and surgery experts who enforce strict academic, clinical, and communication criteria before admission to the network. The platform supports 25+ languages and serves patients from 80+ countries.

The underlying technology combines a multilingual marketplace and case-management workflow with AI-assisted radiology tooling used by specialists to interpret medical images, plus integrations with third-party molecular diagnostics providers for oncology. Diagnose.me holds no patents or proprietary AI models disclosed in the source data, and its technology moat centres on the curated specialist network, Medical Advisory Board vetting, and accumulated case corpus rather than owned model IP.

Diagnose.me monetises through two primary channels. The dominant go-to-market is B2B partnership licensing with 25+ insurance companies and banks (KBC, Raiffeisen, UniCredit, NN, Hannover Re, Vienna Insurance Group brands, etc.) across 15+ Central and Eastern European countries, where services are embedded as employee benefits or policy add-ons reaching 3.5M+ members. A secondary direct-to-consumer channel allows individual patients to self-serve and pay per consultation, with specialists setting their own fees and turnaround times, while oncology tests are priced at €2,500-€3,900 per case. The company is privately held, has raised approximately $638K of disclosed venture funding across 2012-2015, and operates with 11-50 employees.

Diagnose.me firmographics

Firmographics
Name
Diagnose.me
Legal name
Diagnose.me BV
Website
https://diagnose.me
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
Diagnose.me is a Netherlands-based digital health platform founded in 2012 that connects patients from 80+ countries with internationally vetted medical specialists for expert second opinions, personalised oncology, and pathology review, distributed primarily through B2B partnerships with 25+ insurance companies and banks.
Ownership category
akta.pro rank

Diagnose.me industry classification

Industry
Product category
Telemedicine Medical Second Opinion Services
NAICS
Ambulatory Health Care Services (621)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLALALAC
Second Opinion & Expert Matching Platforms
Healthcare & Life Sciences/Telehealth Platforms/Telehealth Marketplace & Referral Platforms
SECONDARYHLALADAI
Second Opinion & Expert Medical Review Platforms
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms
SECONDARYHLAAALAE
Oncology Diagnostics (tumor profiling, MRD, liquid biopsy)

Keywords

  • Medical second opinions
  • Telemedicine consultations
  • Personalised oncology services
  • Digital health platform
  • Pathology review services

Where Diagnose.me is headquartered

Location

Headquarters

HQ city
Amsterdam
HQ country
Netherlands
HQ region
Europe

Offices1 record

Markets served

Diagnose.me business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Expert Medical Opinion Consultation Fees: Specialists set their own consultation fees and delivery times. Patients pay for expert medical opinions from international specialists across various medical specializations.
  2. Personalised Oncology Testing: Diagnostic testing services for cancer treatment personalization. Providers include Oncompass (€3900) and Multiplex DX (€2500), providing comprehensive molecular profiling and treatment recommendations based on tumor genetic features.
  3. Pathology Review Service: Biopsy evaluation service provided through biopsy.me network of international pathologists, analyzing tumor specimens to determine cancer subtypes.
  4. B2B Partnership Licensing: Insurance companies and banks integrate Diagnose.me services as employee benefits or policy add-ons. Partnership models include free benefits for customers, paid add-ons, or themed packages linked to specific policies.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goOncompass comprehensive molecular profiling
Unit PricingPay-as-you-goMultiplex DX breast cancer testing
Unit PricingPay-as-you-goExpert Medical Opinion - Specialist Consultation

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Diagnose.me product offering

Product offering

Core offering

Diagnose.me operates a digital health platform that connects patients with a curated network of international medical specialists for expert second opinions, personalised oncology treatment guidance, and pathology review. Patients select specialists, upload medical data, and receive detailed reports in their preferred language, with services delivered via a web-based platform supporting 25+ languages. The company also offers B2B partnership integrations where insurance companies and banks bundle Diagnose.me services as employee benefits or policy add-ons.

Product overview

Diagnose.me is a digital health platform that provides a curated network of international medical specialists offering expert second opinions. The platform operates three interconnected services: Expert Medical Opinion as the core product for general diagnostic consultations, Personalised Oncology for targeted cancer treatment recommendations based on molecular profiling (providers include Oncompass and Multiplex DX), and Pathology Review for independent biopsy analysis through biopsy.me. All services are delivered via a web-based platform with support for 25+ languages, connecting patients from 80+ countries with specialists from top international hospitals and institutions.

Differentiator

Problem solved

Functional benefit

Brands

  • biopsy.me: Telepathology service provided by Diagnose.me that connects patients to an international network of board-certified pathologists for biopsy reviews.

Products and services

  • Expert Medical Opinion
  • Personalised Oncology
  • Pathology Review

Quantifiable outcome

  • 70% of sales agents report higher conversion rates when offering Diagnose.me services
  • +4 more outcomes

Companies that use Diagnose.me

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Diagnose.me technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature2 records

Diagnose.me partnerships and signals

Strategic signal

Partnerships

31 partnerships are on record, tiered core and major.

  • Bulstrad Life (Vienna Insurance Group)coreChannel Partner/ Reseller/ DistributorMajor insurance partner integrating Diagnose.me services into their product offerings. Bulstrad Life, part of Vienna Insurance Group, offers second medical opinion as part of their life insurance products.
  • TAS LifecoreChannel Partner/ Reseller/ DistributorUkrainian life insurance company providing Diagnose.me services to policyholders. Partnership has delivered services to thousands of clients since inception.
  • NN SlovakiacoreChannel Partner/ Reseller/ DistributorDutch insurance company offering Diagnose.me as health benefits package to Slovak clients. Over 10,000 clients benefited in first three years.
  • AsirommajorChannel Partner/ Reseller/ DistributorInsurance company partner providing second medical opinion services to policyholders.
  • BTA InsurancemajorChannel Partner/ Reseller/ DistributorInsurance partner offering Diagnose.me services to customers.
  • CrosigmajorChannel Partner/ Reseller/ DistributorCroatian insurance company partner.
  • DonarismajorChannel Partner/ Reseller/ DistributorMoldovan insurance company partner.
  • Global Assistance PolandmajorChannel Partner/ Reseller/ DistributorAssistance services provider in Poland.
  • GPIHmajorChannel Partner/ Reseller/ DistributorInsurance partner.
  • Hannover RecoreChannel Partner/ Reseller/ DistributorMajor reinsurance company partner providing support for insurance products.
  • IRAOmajorChannel Partner/ Reseller/ DistributorInsurance partner.
  • KBC GroupcoreChannel Partner/ Reseller/ DistributorBelgian banking and insurance group with presence across CEE.
  • Komunalna poistovnamajorChannel Partner/ Reseller/ DistributorSlovak insurance company partner.
  • KooperativamajorChannel Partner/ Reseller/ DistributorSlovak insurance company partner (Vienna Insurance Group).
  • Liga InsurancemajorChannel Partner/ Reseller/ DistributorInsurance company partner.
  • Makedonija InsurancemajorChannel Partner/ Reseller/ DistributorNorth Macedonian insurance partner.
  • mbankmajorChannel Partner/ Reseller/ DistributorPolish banking institution partner offering Diagnose.me services.
  • Pasha LifemajorChannel Partner/ Reseller/ DistributorAzerbaijani life insurance partner.
  • Postbank BulgariamajorChannel Partner/ Reseller/ DistributorBulgarian bank partner.
  • RaiffeisencoreChannel Partner/ Reseller/ DistributorInternational banking group with presence across CEE.
  • Tatra BankacoreChannel Partner/ Reseller/ DistributorSlovak banking institution partner offering Diagnose.me services through benefits programs.
  • UniCredit BankcoreChannel Partner/ Reseller/ DistributorInternational banking group partner in Slovakia and Czech Republic.
  • Union HungarymajorChannel Partner/ Reseller/ DistributorHungarian insurance company partner.
  • UniqamajorChannel Partner/ Reseller/ DistributorAustrian insurance group with CEE presence.
  • Vienna LifecoreChannel Partner/ Reseller/ DistributorLife insurance brand of Vienna Insurance Group.
  • biopsy.mecoreTechnology or IntegrationTelepathology service provider connecting patients to an international network of board-certified pathologists for comprehensive and precise diagnostic evaluations.
  • OncompasscoreTechnology or IntegrationProvider of comprehensive molecular profiling and personalised therapy planning for cancer treatment. Services include clinical interpretation and tumour board access for EU patients.
  • Multiplex DXcoreTechnology or IntegrationProvider of diagnostic tests for breast cancer, available in EU countries with reports in English or Slovak.
  • Acıbadem Healthcare GroupcoreStrategic or Co-development PartnerTop international hospital and institution part of Diagnose.me's global medical network providing specialist expertise.
  • Rambam Health Care CampuscoreStrategic or Co-development PartnerLeading medical institution in Diagnose.me's global specialist network.
  • Dr. Berezin Medical CentercoreStrategic or Co-development PartnerInternational medical institution providing specialists to Diagnose.me network.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Diagnose.me competitors and assessment

Company assessment

Direct peers

  • Best Doctors (Teladoc Health): Best Doctors pioneered the expert medical second opinion model and is now part of Teladoc Health; it is the closest direct competitor, offering cross-border expert reviews to insurance and employer clients globally.
  • MediGuide: Global second medical opinion provider primarily serving insurance and financial services clients; overlaps directly with Diagnose.me's insurance-embedded B2B model across multiple geographies.
  • Advance Medical: Telemedicine and expert medical opinion provider serving insurers, employers and governments worldwide; competes with Diagnose.me in cross-border expert opinion delivery to payer clients.
  • WorldCare International: Provides international medical second opinions and e-health services to insurance, assistance and corporate clients, comparable in cross-border expert review delivery and payer partnerships.
  • 2nd.MD: US-based second opinion service acquired by Accolade, connecting employees of large US employers with specialist experts for case reviews; directly comparable in product, B2B distribution model and clinical opinion flow.
  • Medix: Global medical management and second opinion company serving insurance and corporate clients across multiple continents; comparable in B2B payer-embedded second opinion and care navigation.

Broad incumbents

  • AXA Health Second Medical Opinion: AXA's embedded second opinion benefit available to policyholders via partnerships; a broader incumbent offering overlapping second opinion capabilities as part of a much larger insurance and health portfolio.
  • Teladoc Health: Largest global telehealth platform offering virtual care, expert medical services and second opinions; broader incumbent whose portfolio includes direct competitors (Best Doctors) to Diagnose.me's expert review offering.
  • Cleveland Clinic MyConsult: Online medical second opinion service from Cleveland Clinic offering expert reviews for a fee; an academic-medical-center incumbent whose offerings compete for the same patient-paid second opinion demand.
  • Doctoralia (Docplanner Group): Global healthcare marketplace connecting patients with specialists and enabling online consultations; broader incumbent in patient-specialist matching with overlapping online second opinion use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Diagnose.me social profiles

Digital presence

Diagnose.me financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Diagnose.me leadership team

Management profile

Number of profiles

Profiles9 records

Diagnose.me funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Diagnose.me M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diagnose.me

What does Diagnose.me do?

Diagnose.me operates a digital health platform that connects patients with a curated network of international medical specialists for expert second opinions, personalised oncology treatment guidance, and pathology review. Patients select specialists, upload medical data, and receive detailed reports in their preferred language, with services delivered via a web-based platform supporting 25+ languages. The company also offers B2B partnership integrations where insurance companies and banks bundle Diagnose.me services as employee benefits or policy add-ons.

Is Diagnose.me a public or private company?

Diagnose.me is a private company. It is classified as venture growth investor backed and is currently operating.

When was Diagnose.me founded?

Diagnose.me was founded in 2012. It employs 11 to 50 people.

Where is Diagnose.me based?

Diagnose.me is headquartered in Amsterdam, Netherlands, in the Europe region.

How does Diagnose.me make money?

Four revenue lines are on record. Expert Medical Opinion Consultation Fees are the primary driver. The others are personalised Oncology Testing, pathology Review Service and B2B Partnership Licensing.

Who are Diagnose.me's main competitors?

Direct peers on record are Best Doctors (Teladoc Health), MediGuide, Advance Medical, WorldCare International, 2nd.MD and Medix. Broad incumbents are AXA Health Second Medical Opinion, Teladoc Health, Cleveland Clinic MyConsult and Doctoralia (Docplanner Group).

Does Diagnose.me have an API?

No public API is recorded for Diagnose.me.

What industry is Diagnose.me in?

Diagnose.me's product category is Telemedicine Medical Second Opinion Services. Its primary akta.pro industry code is HLALALAC, Second Opinion & Expert Matching Platforms, with a secondary code of HLALADAI, Second Opinion & Expert Medical Review Platforms. Its NAICS code is 621 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales